Canopy(1) | $22,000,000 | (Jan 13, 2026)
Onsetto | $2,200,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
Talos
United States
- New York, NY
- 10/05/2022
- Series B
- $105,000,000
Delivering institutional-grade infrastructure for digital assets trading.
- Industry Financial Services
- Website https://talos.com/
- LinkedIn https://www.linkedin.com/company/talos-trading/
Related People
Anton KatzFounder
United States -
New York, New York,
Talos provides an institutional-grade technology infrastructure that supports the full lifecycle of digital assets trading, from price discovery to execution through to settlement. Engineered by a team with unmatched experience building institutional trading systems, the Talos platform connects the diverse group of participants involved in today's crypto-asset market structure – institutional investors, prime brokers, exchanges, OTC desks, lenders, and custodians – through a single point of entry. This streamlines the entire trading process, eliminates unnecessary intermediary risk, and provides institutions a clear path to best execution. Launched in August 2019, the Talos platform delivers a suite of solutions across spot, futures, and FX markets.
For additional information, visit www.talos.com.
Cytotheryx, Inc. | $60,000,000 | (Jan 13, 2026)
MEDIPOST, Inc. | $140,000,000 | (Jan 13, 2026)
TRYBE | $30,000,000 | (Jan 13, 2026)
Kinaset Therapeutics | $103,000,000 | (Jan 13, 2026)
Diagonal Therapeutics | $125,000,000 | (Jan 13, 2026)
VelaFi | $20,000,000 | (Jan 13, 2026)
encoord | $2,000,000 | (Jan 13, 2026)
Vibrant Therapeutics | $61,000,000 | (Jan 13, 2026)
Avenue Biosciences | $7,500,000 | (Jan 13, 2026)
Unusual | $3,600,000 | (Jan 13, 2026)